Hyperthermic Intraperitoneal Chemotherapy: Clinical Trials

117 trials of Hyperthermic Intraperitoneal Chemotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

37 unknown, 32 completed, 19 recruiting, 10 active not recruiting. 48 Phase 2, 29 Phase 3, 14 Not applicable, 8 Phase 1, 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 248Completed 13, Unknown 10, Recruiting 9, Active not recruiting 4, Not yet recruiting 4, Terminated 3, Withdrawn 3, Enrolling by invitation 1, Suspended 1
Phase 329Unknown 16, Active not recruiting 4, Completed 4, Recruiting 3, Not yet recruiting 1, Terminated 1
Not applicable14Terminated 5, Unknown 5, Completed 3, Recruiting 1
Phase 18Completed 6, Recruiting 1, Withdrawn 1
Early Phase 13Active not recruiting 1, Recruiting 1, Terminated 1
Phase 41Recruiting 1

Follow Hyperthermic Intraperitoneal Chemotherapy: new trials by email Literature Review of Hyperthermic Intraperitoneal Chemotherapy trials Research Report on Hyperthermic Intraperitoneal Chemotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer
Hyperthermic Intraperitoneal Chemotherapy, Serplulimab, S-1 - Locally Advanced Gastric Cancer, Gastric Adenocarcinoma
Phase 2RecruitingShanghai Changzheng Hospital482026-07-132026-10-22
To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.
Pancreatectomy, Complete Cytoreduction, Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - Pancreatic Adenocarcinoma, Peritoneal (Metastatic) Cancer
Not applicableRecruitingUnidade Local de Saúde São João, Oporto202026-03-012026-03-25
Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)
Heated intra-peritoneal chemotherapy, Aerosolized intra-peritoneal chemotherapy - Peritoneal (Metastatic) Cancer, Peritoneal Carcinomatosis
Phase 2RecruitingPatrick Wagner, MD, FACS2002026-01-052026-02-27
A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10
HIPEC, NIPS, Paclitaxel Injection, S-1, tislelizumab - Gastric Cancer Peritoneal Metastases
Phase 2Not yet recruitingHebei Medical University302025-12-122025-12-26
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence
Biopsy Procedure, Biospecimen Collection, Cisplatin - Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
Phase 2Enrolling by invitationMayo Clinic162025-12-032026-07-01
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer
curative-intent surgery + HIPEC - Gastric Cancer (GC), HIPEC
RecruitingUkrainian Society of Clinical Oncology2002025-12-012026-01-13
INTERACT Stomach-II
intraperitoneal chemotherapy - Peritoneal Metastases From Gastric Cancer
Phase 2RecruitingErasmus Medical Center552025-10-012026-10-21
Effects of HIPEC on Postoperative Bowel Motility and Complications
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - HIPEC, Gastro Intestinal Cancer
Active not recruitingPeking University People's Hospital1932025-04-202026-01-20
The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cisplatin + Systemic AG Chemotherapy - Hyperthermic Intraperitoneal Chemotherapy, Peritoneal Metastatic Pancreatic Cancer
Phase 2RecruitingShanghai Zhongshan Hospital902025-04-032025-04-27
A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis
HIPEC, SOX, Immune Checkpoint Inhibitors - Gastric Cancer
Phase 2RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology342025-02-152025-04-11
Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)
Mitomycin c - Pseudomyxoma Peritonei
Phase 3RecruitingUniversity of Southampton1762024-12-042026-02-19
A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer
Tislelizumab, SOX, HIPEC - Gastric Cancer, Gastroesophageal Junction Cancer
RecruitingSouthwest Hospital, China1222024-12-012025-01-07
Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients
Secondary cytoreduction, Hyperthermic intraperitoneal chemotherapy - Ovarian Cancer
Phase 2Not yet recruitingFudan University942024-08-312024-08-09
The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM
HIPEC, Systemic therapy - Gastric Cancer, Metastatic
Phase 2Active not recruitingThe First Affiliated Hospital with Nanjing Medical University502024-05-312025-07-16
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
Cisplatin, Hyperthermic Intraperitoneal Chemotherapy, Nab-paclitaxel - Metastatic Pancreatic Carcinoma, Stage IV Pancreatic Cancer AJCC v8
Phase 2Active not recruitingMayo Clinic402024-02-152026-10-15
Intraperitoneal LSTA1 in CRS-HIPEC
CRS-HIPEC + LSTA1, CRS-HIPEC alone - Colorectal Cancer, Ovarian Carcinoma
Phase 1WithdrawnUniversity of California, San Diego2023-11-302024-08-20
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study
Cisplatin, Computed Tomography, Gastrectomy - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Phase 2RecruitingMayo Clinic402023-04-202026-04-08
HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy
HIPEC - Gastric Cancer, Peritoneal Metastases
Phase 2 / Phase 3Not yet recruitingZhixin Cao2002023-01-012022-12-06
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - Gastric Cancer
Phase 3RecruitingThe Affiliated Hospital of Qingdao University6162022-11-202026-03-06
Glycocalyx Monitoring in Major Abdominal Surgery
Cytoreduction surgery with Hyperthermic Intraperitoneal Chemotherapy, Cephalic DuodenoPancreatectomy - Major Abdominal Surgery
CompletedUniversity Hospital, Rouen782022-07-052026-05-22

Showing 20 of 117. Sign in to see all of them.

Conditions studied

Stomach Neoplasms (34)  ·  Ovarian Neoplasms (31)  ·  Peritoneal Neoplasms (28)  ·  Colorectal Neoplasms (14)  ·  Fallopian Tube Neoplasms (14)  ·  Carcinoma, Ovarian Epithelial (13)  ·  Appendiceal Neoplasms (7)  ·  Neoplasm Metastasis (5)  ·  Pancreatic Neoplasms (4)  ·  Carcinoma (3)  ·  Neoplasms (3)  ·  Pseudomyxoma Peritonei (3)  ·  Recurrence (3)  ·  Uterine Neoplasms (3)  ·  Colonic Neoplasms (2)

Sponsors

Wuhan University (6)  ·  Affiliated Cancer Hospital & Institute of Guangzhou Medical University (4)  ·  Fudan University (4)  ·  Hospices Civils de Lyon (4)  ·  Mayo Clinic (4)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (3)  ·  Wake Forest University Health Sciences (3)  ·  City of Hope Medical Center (2)  ·  Loma Linda University (2)  ·  M.D. Anderson Cancer Center (2)  ·  National Cancer Center, Korea (2)  ·  Shu-Zhong Cui (2)  ·  University Hospital Tuebingen (2)  ·  Zhejiang Cancer Hospital (2)  ·  A.O. Ospedale Papa Giovanni XXIII (1)

Countries

China (41)  ·  United States (28)  ·  France (9)  ·  Germany (7)  ·  Spain (7)  ·  Belgium (5)  ·  Netherlands (4)  ·  South Korea (3)  ·  Switzerland (3)  ·  Austria (2)  ·  Italy (2)  ·  Poland (2)  ·  Singapore (2)  ·  Argentina (1)  ·  Australia (1)

Top investigators

Shuzhong Cui, M.D (2)  ·  Zhongqiu Lin, M.D (2)  ·  Aaron S Mansfield (1)  ·  Andre Roncon Dias, MD, PhD (1)  ·  Andrea Hayes-Jordan, MD (1)  ·  Andrea Jewell, MD (1)  ·  Anna Fagotti, MD, PhD (1)  ·  Armando Sardi, M.D. (1)  ·  Beate Rau, Prof. (1)  ·  Brian Boone, MD (1)  ·  Brian D Badgwell (1)  ·  Cornelius A. Thiels, DO, MBA (1)

Results publications

PMID 16394300, PMID 16485159, PMID 17708508, PMID 19169758, PMID 21424369, PMID 21448361, PMID 24378877, PMID 24628950, PMID 26669784, PMID 26811651, PMID 26903580, PMID 27633880, PMID 27650694, PMID 28273222, PMID 29263704, PMID 29743140, PMID 30131226, PMID 30473706, PMID 30954352, PMID 31060544, PMID 31069579, PMID 32556731, PMID 32594200, PMID 32667582, PMID 32696309, PMID 32717180, PMID 33198674, PMID 35100917, PMID 35262624, PMID 35549912, PMID 35712968, PMID 36608383, PMID 37596449, PMID 37673112, PMID 37690994, PMID 37906724, PMID 37916797, PMID 39549720, PMID 39760061, PMID 39955184, PMID 40115934, PMID 40953882, PMID 41888710, PMID 42419336

NIH funding

2009 (3), 2015 (2), P30CA033572 (2), 2014 (1), 2016 (1), 2018 (1), 2019 (1), 2025 (1), P30CA012197 (1), U10CA180821 (1)